**Core Concept:** Beta-blockers are a class of medications that block the effects of beta-adrenergic stimulation, which is involved in the stress response and cardiovascular pathology. They are used to treat hypertension, angina, and heart failure. Beta-1 receptors are primarily responsible for the cardiovascular effects of catecholamines such as adrenaline and noradrenaline.

**Why the Correct Answer is Right:** Carvedilol is a beta-blocker that blocks both beta-1 and beta-2 receptors. This makes it a non-selective beta-blocker, which means it has effects on both cardiovascular and non-cardiovascular systems. As a result, it is used to treat hypertension, angina, and heart failure.

**Why Each Wrong Option is Incorrect:**

A. ACE inhibitors are not beta-blockers; they are used to treat hypertension, angina, and heart failure by blocking the conversion of angiotensin I to angiotensin II.

B. ACE inhibitors are not beta-blockers; they are used to treat hypertension, angina, and heart failure by blocking the conversion of angiotensin I to angiotensin II.

C. Angiotensin II receptor blockers (ARBs) are not beta-blockers; they are used to treat hypertension, angina, and heart failure by blocking angiotensin II receptors.

D. Calcium channel blockers are not beta-blockers; they are used to treat hypertension by blocking calcium channels in cardiac myocytes, thereby reducing the force of contraction and lowering blood pressure.

**Clinical Pearl:** Beta-blockers are a crucial class of medications in the management of cardiovascular diseases. While ACE inhibitors, ARBs, and calcium channel blockers are effective treatments for hypertension and heart failure, they target different pathways (ACE, angiotensin II, and calcium channels, respectively) and are not considered beta-blockers.

**Correct Answer:** Beta-blockers (including carvedilol) are essential in the management of hypertension, angina, and heart failure by blocking beta-1 receptors, reducing heart rate, and decreasing cardiac output.